Optimizing the Management of Early-stage TNBC: Symptoms, Treatments, and Recurrence
November 3, 2022
Triple-negative breast cancer (TNBC) accounts for about 10-15% of all breast cancers. Dr. Regina Hampton, a board-certified general surgeon with a focus on breast health and breast cancer in the DC Metro area, explains why TNBC differs from other types of invasive breast cancer, why it has fewer treatment options, and why it tends to have a worse outcome when compared with other early-stage breast cancers. Dr. Hampton also sheds light on the recurrence rate and what percentage of TNBC patients become metastatic. Everyone can benefit from attending this eye-opening webinar, especially Black women.
Key takeaways from webinar viewers:
- "I’ve seen a lot of webinars about TNBC, and this one was definitely at the top of the list! I am a Caucasian woman and it was incredibly helpful to me, and heartened me to hear about the increased support for women of color."
- "I learned the value of clinical trials for TNBC."
- "Dr. Hampton is an excellent orator who presented comprehensive, clear, well organized & slides. She also handled all questions succinctly and provided extra information accordingly."
- "The information was comprehensive and helpful, and both the doctor and the moderator were terrific!"